PXSProvexisPXS info
$0.01info0.46%24h
Global rank30324
Market cap$19.01M
Change 7d0.46%
YTD Performance-5.77%
SP500 benchmarkUnderperform
P/E-42.87
P/S37.13
Revenue$511.94K
Earnings-$508.26K
Dividend yield-
Main Sector
Healthcare

Provexis (PXS) Stock Overview

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

PXS Stock Information

Symbol
PXS
Address
I FordReading, RG1 1AZUnited Kingdom
Founded
-
Trading hours
8:00 AM - 4:30 PM GMT
Website
https://www.provexis.com
Country
🇬🇧 United Kingdom
Phone Number
44 7490 391888

Provexis (PXS) Price Chart

-
Value:-

Provexis Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.008573491761307686
N/A
Market Cap
$19.01M
N/A
Shares Outstanding
2.22B
0.27%
Employees
2.00
N/A
Shareholder Equity
657.65K
-32.14%
Valuation
2023
Change
P/E Ratio
-42.87
N/A
P/S Ratio
37.13
N/A
P/B Ratio
28.90
N/A
Growth
2023
Change
Return on Equity
-0.7728
N/A
Earnings
2023
Change
Revenue
$511.94K
N/A
Earnings
-$508.26K
N/A
EPS
-0.0002
N/A
Earnings Yield
-0.0233
N/A
Gross Margin
0.7551
N/A
Operating Margin
-1.08
N/A
Net income margin
-0.9928
N/A
Financial Strength
2023
Change
Total Assets
$1.11M
N/A
Cash on Hand
$497.76K
N/A
Debt to Equity
0.3760
75.75%
Current Ratio
$4.49
-37.06%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org